Reagents which regulate human neuropeptide Y-like G protein-coupled receptor
(NPY-like GPCR) protein and reagents which bind to human NPY-like GPCR gene products
can play a role in preventing, ameliorating, or correcting dysfunctions or diseases
including, but not limited to, obesity, diabetes, anxiety, hypertension, cocaine
withdrawal, congestive heart failure, memory enhancement, cardiac and cerebral
vasospasm, pheochromocytoma, ganglioneuroblastoma, Huntington's disease, Alzheimer's
disease, and Parkinson's disease.
